TNF Pharmaceuticals, Inc.

LSE:0A8D Stock Report

Market Cap: US$4.1m

TNF Pharmaceuticals Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenure4.6yrs

Recent management updates

Recent updates


CEO

TNF Pharmaceuticals has no CEO, or we have no data on them.


Board Members

NamePositionTenureCompensationOwnership
Mitchell Glass
Presidentno datano datano data
Joshua Silverman
Independent Chairman of the Board5.9yrsUS$216.00k0.21%
$ 8.7k
Stephen Friscia
Directorless than a yearno datano data
Christopher Schreiber
Director7yrsUS$310.89k0%
$ 0
Craig Eagle
Independent Director3.3yrsUS$96.00k0%
$ 0
Billy White
Independent Director7yrsUS$96.00k0%
$ 0
Jeremy Walston
Member of Scientific Advisory Boardno datano datano data
Jude Uzonwanne
Independent Director3.3yrsUS$96.00k0%
$ 0

4.6yrs

Average Tenure

58yo

Average Age

Experienced Board: 0A8D's board of directors are considered experienced (4.6 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.